Half-Life of Liothyronine
The elimination half-life of liothyronine (T3) is approximately 2.5 days (about 2-2.5 days), though it exhibits biphasic elimination kinetics with a rapid distribution phase of 2.3 hours and a slower terminal elimination phase of approximately 23 hours. 1
Pharmacokinetic Profile
The FDA drug label clearly states that liothyronine has a biological half-life of about 2-1/2 days 1. This relatively short half-life compared to levothyroxine (T4, which has a half-life of approximately 7 days) has important clinical implications:
Key Pharmacokinetic Characteristics:
- Rapid onset of action: Occurs within a few hours of administration 1
- Peak effect: Maximum pharmacologic response occurs within 2-3 days 1
- Absorption: Almost totally absorbed (95% in 4 hours) 1
- Time to maximum concentration: 1.8 hours 2
Biphasic Elimination Pattern
More recent research has refined our understanding of liothyronine elimination, demonstrating a two-compartment model 2:
- Fast distribution phase: Half-life of 2.3 ± 0.11 hours
- Slow elimination phase: Half-life of 22.9 ± 7.7 hours
This biphasic pattern explains why the traditional "2.5 day" half-life represents an average, and why liothyronine's metabolic effects persist for several days following discontinuation despite its rapid initial clearance 1.
Clinical Implications
Advantages of Short Half-Life:
- Rapid dosage adjustment capability: Allows quick titration when needed 1
- Easier management of overdosage: Quick cutoff of activity facilitates control if toxicity occurs 1
- Useful for thyroid scanning procedures: Induction of hypothyroidism is more abrupt and can be of shorter duration 1
Disadvantages:
- Wide serum T3 swings: The short half-life leads to more pronounced fluctuations in serum T3 levels throughout the day 1
- Potential for cardiovascular side effects: These fluctuations may increase risk of cardiovascular complications 1
- Multiple daily dosing considerations: The pharmacokinetics support twice-daily or thrice-daily dosing to maintain stable levels 2
Common Pitfall
Do not assume liothyronine is completely cleared after one half-life. While the drug has rapid distribution and initial clearance, its metabolic effects persist for several days after discontinuation 1. When switching patients from other thyroid preparations to liothyronine, residual effects of the previous medication may persist for the first several weeks of therapy 1.